BioTherapeutics' immunoglobulin therapies treat primary immunodeficiencies (PIs) associated with defects in humoral immunity or a lack of antibody production. In addition to immunoglobulin therapies, BioTherapeutics also produces antibody-replacement therapies to bolster the immune system of people with secondary immunodeficiencies and recurrent infections. Immunoglobulin therapies also include treatments for immune thrombocytopenic purpura ITP in patients with low platelet counts.
For additional resources, please click here.
| Product | Primary Uses | Product Description |
| GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% (US) | Primary immunodeficiency (PI) diseases | Ready-to-use 10% sterile, liquid preparation of highly purified and concentrated IgG antibodies |
| Solution for infusion (10%) Human normal immunoglobulin (IGIV) (International) | PI diseases and secondary immunodeficiency (SI) disorders, replacement therapy in children with congenital AIDS, ITP, Guillain-Barré syndrome, Kawasaki disease, allogeneic bone marrow transplantation | 1mL contains 100 mg of IGIV solution for infusion |
| GAMMAGARD S/D [Immune Globulin Intravenous (Human)] (US) | PI diseases, B-cell chronic lymphocytic leukemia, ITP, Kawasaki syndrome | Solvent/detergent treated, sterile, freeze-dried preparation of highly purified IgG |
| Human Normal Immunoglobulin (IGIV) (International) | PI diseases and SI disorders, children with AIDS, ITP, Guillain-Barré syndrome, Kawasaki disease, allogeneic bone marrow transplantation | Powder and solvent for solution containing .5g, 2.5g, 5g, and 10g IgG per vial |
| GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 μg/mL in a 5% solution (US) | PI diseases, B-cell chronic lymphocytic leukemia, ITP, Kawasaki syndrome | Solvent/detergent treated, sterile, freeze-dried preparation of highly purified IgG |
| Human Normal Immunoglobulin for Subcutaneous Use (International) | PI diseases or SI disorders with recurrent infections | 16% solution of polyvalent human normal immunoglobulin for subcutaneous infusion |
| Human tetanus immunoglobulin for intramuscular use (International) | Post-exposure prophylaxis Clinically manifested tetanus |
Ready-to-use 16% solution for IM use |
| Human anti-D immunoglobulin for intramuscular use (International) | Prevention of Rh(D) immunisation in Rh(D)-negative women | Ready-to-use 16% solution for IM use |
Ready-to-use 10% sterile, liquid preparation
Read More [+]
A comprehensive portfolio of Ig products for all treatment settings - hospital, outpatient, clinic, and home.
Please consult your local approved product labeling for prescribing information. Please note that not all products are licensed in all countries.